Cetera Investment Advisers’s TG Therapeutics TGTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.71M | Buy |
47,628
+311
| +0.7% | +$11.2K | ﹤0.01% | 1961 |
|
2025
Q1 | $1.87M | Sell |
47,317
-4,882
| -9% | -$192K | ﹤0.01% | 1800 |
|
2024
Q4 | $1.57M | Sell |
52,199
-512
| -1% | -$15.4K | ﹤0.01% | 1823 |
|
2024
Q3 | $1.23M | Sell |
52,711
-714
| -1% | -$16.7K | ﹤0.01% | 1974 |
|
2024
Q2 | $950K | Sell |
53,425
-9,652
| -15% | -$172K | ﹤0.01% | 2109 |
|
2024
Q1 | $959K | Buy |
63,077
+26,693
| +73% | +$406K | ﹤0.01% | 2101 |
|
2023
Q4 | $621K | Sell |
36,384
-7,017
| -16% | -$120K | 0.01% | 1377 |
|
2023
Q3 | $363K | Buy |
43,401
+2,634
| +6% | +$22K | ﹤0.01% | 1600 |
|
2023
Q2 | $1.01M | Buy |
40,767
+3,593
| +10% | +$89.3K | 0.01% | 1056 |
|
2023
Q1 | $559K | Buy |
37,174
+18,605
| +100% | +$280K | ﹤0.01% | 1363 |
|
2022
Q4 | $220K | Sell |
18,569
-255
| -1% | -$3.02K | ﹤0.01% | 1851 |
|
2022
Q3 | $111K | Buy |
18,824
+200
| +1% | +$1.18K | ﹤0.01% | 1573 |
|
2022
Q2 | $79K | Buy |
18,624
+1,311
| +8% | +$5.56K | ﹤0.01% | 1750 |
|
2022
Q1 | $165K | Sell |
17,313
-4,346
| -20% | -$41.4K | ﹤0.01% | 1752 |
|
2021
Q4 | $412K | Buy |
21,659
+2,914
| +16% | +$55.4K | 0.01% | 1300 |
|
2021
Q3 | $624K | Buy |
18,745
+6,246
| +50% | +$208K | 0.01% | 1011 |
|
2021
Q2 | $485K | Buy |
+12,499
| New | +$485K | 0.01% | 1139 |
|